Potential of Black Phosphorus in Immune‐Based Therapeutic Strategies

Wenjuan Dong, Wang Hu, Hailin Liu, Chunqiao Zhou, Xuelin Zhang, Song Wang, He LinBioinorganic 2022 · DOI

TL;DR

This review explores the exciting potential of black phosphorus (BP) as a versatile nanomaterial for advanced cancer immunotherapy. BP's unique properties enable it to act as a powerful platform for various therapeutic strategies, including photothermal and photodynamic therapies, and crucially, to stimulate potent anti-cancer immune responses.

What Problem Does This Paper Address?

Cancer immunotherapy has revolutionized treatment, but its effectiveness is limited for many patients. Challenges include immune escape, drug resistance, and the need for more potent and targeted therapies. While existing immunotherapies show promise, there's a critical need for novel agents that can overcome these hurdles and elicit a robust, long-lasting anti-tumor immune response. This paper addresses this by investigating black phosphorus (BP), a 2D material with unique properties that make it a promising candidate for developing next-generation cancer immunotherapies.

Methods

The paper is a review article, so it doesn't present novel experimental methods. Instead, it synthesizes and analyzes existing research on black phosphorus (BP) for its applications in cancer immunotherapy. The authors discuss various strategies for functionalizing and stabilizing BP, including:

  • Encapsulation: Coating BP with polymers, 2D heterostructures, nanoparticles, or biomembranes to improve its stability and dispersibility.
  • Chemical Modification: Covalently altering BP's surface through nucleophilic substitution, radical reactions, or metal coordination to enhance its properties.
  • Element Doping: Incorporating specific atoms into the BP structure to improve its stability and tune its electronic properties.

The review then delves into BP's therapeutic applications, focusing on how its physical and chemical properties are leveraged for:

  • Photothermal Therapy (PTT) & Photodynamic Therapy (PDT): BP's ability to absorb near-infrared (NIR) light and convert it into heat or reactive oxygen species (ROS) to kill cancer cells.
  • Sonodynamic Therapy (SDT) & Photoacoustic Therapy (PAT): Utilizing ultrasound or NIR irradiation to generate ROS and shockwaves for enhanced cancer cell destruction.
  • Photoimmunotherapy (PIT): A key focus, where BP-induced cell death (via PTT, PDT, SDT, or PAT) triggers the release of tumor antigens, leading to an in situ anti-cancer vaccine and subsequent immune activation.
  • Nanovaccines & Nanoadjuvants: BP's role in developing advanced vaccine platforms and immune-boosting agents.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • BP as a "Double-Kill" Agent: BP's ability to directly damage tumor cells through photothermal, photodynamic, sonodynamic, or photoacoustic effects, and subsequently trigger a potent anti-tumor immune response, is a significant advantage. This "double-kill" mechanism offers a more comprehensive approach to cancer treatment.
  • PIT's Power: Photoimmunotherapy (PIT) is highlighted as a particularly promising strategy. By inducing immunogenic cell death (ICD), BP facilitates the release of tumor antigens, effectively creating an "in situ vaccine" that trains the immune system to recognize and attack cancer cells.
  • Versatility of BP: BP isn't limited to one therapeutic modality. Its tunable properties allow it to be adapted for a wide range of applications, from drug delivery and imaging to various forms of phototherapy and immunotherapy.
  • Overcoming Graphene's Limitations: BP offers a compelling alternative to graphene in nanomedicine due to its inherent biodegradability and lower cytotoxicity, addressing key concerns associated with graphene-based therapies.
  • Functionalization is Key: The stability and efficacy of BP in biological applications are heavily dependent on effective functionalization strategies, which are crucial for its translation into clinical use.

Key Results

While this is a review, the paper synthesizes findings from numerous studies, indicating:

  • Effective Tumor Ablation: BP-based PTT has demonstrated significant temperature increases in tumor sites, sufficient to ablate tumor cells.
  • ROS Generation: BP effectively generates ROS under NIR irradiation, crucial for PDT and SDT.
  • Enhanced Immune Response: BP-based PIT has shown to promote the maturation of dendritic cells (DCs) and induce antigen-specific cytotoxic T cell (CTL) responses.
  • Synergistic Effects: Combinations of BP-based therapies with immune checkpoint inhibitors (e.g., anti-PD-1, anti-CTLA-4) and macrophage immunotherapy have shown enhanced anti-tumor efficacy, inhibiting tumor growth and metastasis.
  • Improved Stability: Various functionalization strategies have successfully improved the stability of BP in ambient conditions, making it more amenable to biomedical applications.

Limitations and Future Work

The authors acknowledge several limitations and suggest future directions:

  • Preparation Challenges: The industrial-scale production of BP remains a significant challenge.
  • Stability Issues: Despite advancements, improving the long-term stability of BP in physiological environments is crucial for practical applications.
  • Cytotoxicity Complexity: The mechanisms of BP-induced cytotoxicity are complex and require further evaluation to ensure safety for biomedical use.
  • Precise Design: The dual nature of BP (promoting and inhibiting immune responses) necessitates precise design of its structure and function to optimize therapeutic outcomes.
  • Clinical Translation: While promising, further research is needed to translate these findings into effective clinical treatments for cancer patients. Future work should focus on optimizing BP-based nanomedicines for targeted delivery, enhanced efficacy, and reduced side effects.

Summary updated

Abstract

Black phosphorus (BP) consists of phosphorus atoms, an essential element of bone and nucleic acid, which covalently bonds to three adjacent phosphorus atoms to form a puckered bilayer structure. With its anisotropy, band gap, biodegradability, and biocompatibility properties, BP is considered promising for cancer therapy. For example, BP under irradiation can convert near-infrared (NIR) light into heat and reactive oxygen species (ROS) to damage cancer cells, called photothermal therapy (PTT) and photodynamic therapy (PDT). Compared with PTT and PDT, the novel techniques of sonodynamic therapy (SDT) and photoacoustic therapy (PAT) exhibit amplified ROS generation and precise photoacoustic-shockwaves to enhance anticancer effect when BP receives ultrasound or NIR irradiation. Based on the prospective phototherapy, BP with irradiation can cause a "double-kill" to tumor cells, involving tumor-structure damage induced by heat, ROS, and shockwaves and a subsequent anticancer immune response induced by in situ vaccines construction in tumor site, which is referred to as photoimmunotherapy (PIT). In conclusion, BP shows promise in natural antitumor biological activity, biological imaging, drug delivery, PTT/PDT/SDT/PAT/PIT, nanovaccines, nanoadjuvants, and combination immunotherapy regimens.
BibTeX
@inproceedings{dong2022potential,
  author = {Wenjuan Dong and Wang Hu and Hailin Liu and Chunqiao Zhou and Xuelin Zhang and Song Wang and He Lin},
  title = {{Potential of Black Phosphorus in Immune‐Based Therapeutic Strategies}},
  booktitle = {Bioinorganic},
  year = {2022},
  doi = {10.1155/2022/3790097},
}
Figure